NYSE:DHRLife Sciences
Assessing Danaher (DHR) Valuation After Earnings Beat And Optimistic Analyst Sentiment
Danaher (DHR) shares have reacted to a busy stretch of news, with quarterly results that topped Wall Street revenue forecasts. Adjusted EPS growth has drawn attention despite the stock lagging the broader market over the past year.
See our latest analysis for Danaher.
At around $219.75, Danaher's recent 1-day and 7-day share price returns of about 1% suggest a modest positive reaction to the earnings beat and board changes. The 1-year total shareholder return of roughly 10% contrasts with...